CARDIFF ONCOLOGY, INC. Payments for Legal Settlements
CARDIFF ONCOLOGY, INC. (CRDF) reported Payments for Legal Settlements of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForLegalSettlements · last filed 2026-02-24
- CARDIFF ONCOLOGY, INC. payments for legal settlements for fiscal 2025 was $400.00K, a 0.00% change from fiscal 2024.
- CARDIFF ONCOLOGY, INC. payments for legal settlements for fiscal 2024 was $400.00K.
| Period end | Payments for Legal Settlements 1 month | Payments for Legal Settlements 12 month |
|---|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-02-24 | |
| 2024-12-31 | $400.00K 10-K · filed 2025-02-27 | |
| 2024-09-30 | $400.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |